相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157
Diego Rojas-Rivera et al.
CELL DEATH AND DIFFERENTIATION (2017)
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
K. Newton et al.
CELL DEATH AND DIFFERENTIATION (2016)
CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3
Jinho Seo et al.
NATURE CELL BIOLOGY (2016)
Potent and selective bivalent inhibitors of BET bromodomains
Michael J. Waring et al.
NATURE CHEMICAL BIOLOGY (2016)
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Celine Berthon et al.
LANCET HAEMATOLOGY (2016)
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
Sandy Amorim et al.
LANCET HAEMATOLOGY (2016)
Ppm1b negatively regulates necroptosis through dephosphorylating Rip3
Wanze Chen et al.
NATURE CELL BIOLOGY (2015)
A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis
Dianrong Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis
Hyo-Sun Choi et al.
TRANSLATIONAL RESEARCH (2015)
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
A. Fauster et al.
CELL DEATH & DISEASE (2015)
Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
Malek Najjar et al.
CELL REPORTS (2015)
Activation of Necroptosis in Multiple Sclerosis
Dimitry Ofengeim et al.
CELL REPORTS (2015)
Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death
Xin Chen et al.
CELL RESEARCH (2014)
Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
Huayi Wang et al.
MOLECULAR CELL (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury
J-X Li et al.
CELL DEATH & DISEASE (2014)
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
Sarah Picaud et al.
CANCER RESEARCH (2013)
Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis
Jianfeng Wu et al.
CELL RESEARCH (2013)
BET bromodomain inhibition suppresses TH17-mediated pathology
Deanna A. Mele et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The Making of I-BET762, a BET Bromodomain Inhibitor Now in Clinical Development
Yujun Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death
Dimitry Ofengeim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Bach1 is critical for the transformation of mouse embryonic fibroblasts by RasV12 and maintains ERK signaling
A. Nakanome et al.
ONCOGENE (2013)
Two faces of BRD4 Mitotic bookmark and transcriptional lynchpin
Ballachanda N. Devaiah et al.
TRANSCRIPTION-AUSTIN (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis
Jie Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
Linde Duprez et al.
IMMUNITY (2011)
The Ripoptosome: Death Decision in the Cytosol
Mathieu J. M. Bertrand et al.
MOLECULAR CELL (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
YoungSik Cho et al.
CELL (2009)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
TNF-α induces two distinct caspase-8 activation pathways
Lai Wang et al.
CELL (2008)
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
ZY Yang et al.
MOLECULAR CELL (2005)
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
A Degterev et al.
NATURE CHEMICAL BIOLOGY (2005)
Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein
C Pivot-Pajot et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
分享论文
